5CV.DE

CureVac N.V. [5CV.DE] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

5CV.DE Stock Summary

Top 10 Correlated ETFs

5CV.DE


Top 10 Correlated Stocks

5CV.DE


In the News

5CV.DE Financial details

Company Rating
Neutral
Market Cap
640.31M
Income
-302.3M
Revenue
42.88M
Book val./share
2.69
Cash/share
2.09
Dividend
-
Dividend %
-
Employees
904
Optionable
No
Shortable
Yes
Earnings
24 Apr 2024
P/E
-2.7
Forward P/E
-3.43
PEG
0.81
P/S
20.08
P/B
1.36
P/C
1.36
P/FCF
-2.57
Quick Ratio
3.25
Current Ratio
3.56
Debt / Equity
0.07
LT Debt / Equity
0.06
-
-
EPS (TTM)
-1.47
EPS next Y
-0.83
EPS next Q
-0.19
EPS this Y
-40.27%
EPS next Y
-43.43%
EPS next 5Y
-49.66%
EPS last 5Y
26.97%
Revenue last 5Y
39.26%
Revenue Q/Q
117.48%
EPS Q/Q
-26.67%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-40%
Inst Own
-
Inst Trans
-
ROA
-36%
ROE
-48%
ROC
-0.44%
Gross Margin
-252%
Oper. Margin
-718%
Profit Margin
-705%
Payout
-
Shs Outstand
223.88M
Shs Float
91.6M
-
-
-
-
Target Price
-
52W Range
2.53-11.28
52W High
-74.09%
52W Low
+42.5%
RSI
42
Rel Volume
0.62
Avg Volume
87.1K
Volume
54.04K
Perf Week
2.15%
Perf Month
-10.38%
Perf Quarter
-50.69%
Perf Half Y
-59.05%
-
-
-
-
Beta
2.531
-
-
Volatility
0.04%, 0.16%
Prev Close
0%
Price
2.85
Change
1.79%

5CV.DE Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.070.10.270.550.36
Net income per share
-0.4-0.57-0.72-2.21-1.32
Operating cash flow per share
-0.42-0.492.89-3.94-1.51
Free cash flow per share
-0.5-0.562.63-4.63-2.01
Cash per share
0.340.187.344.392.65
Book value per share
0.18-0.243.943.72.82
Tangible book value per share
0.15-0.283.863.632.65
Share holders equity per share
0.18-0.243.943.72.82
Interest debt per share
00.460.290.210.24
Market cap
7.14B7.14B13.23B5.62B1.07B
Enterprise value
7.12B7.19B11.94B4.83B616.45M
P/E ratio
-100.23-71.5-102.51-13.64-4.3
Price to sales ratio
554.8410.01270.5854.5315.87
POCF ratio
-96.35-82.1125.33-7.66-3.74
PFCF ratio
-80.38-71.9927.85-6.52-2.82
P/B Ratio
222.57-166.8318.68.162.01
PTB ratio
222.57-166.8318.68.162.01
EV to sales
553.14412.8244.1546.939.14
Enterprise value over EBITDA
-106.14-78.57-108.73-12.51-2.76
EV to operating cash flow
-96.07-82.6722.85-6.59-2.15
EV to free cash flow
-80.14-72.4825.13-5.61-1.62
Earnings yield
-0.01-0.01-0.01-0.07-0.23
Free cash flow yield
-0.01-0.010.04-0.15-0.35
Debt to equity
0.01-1.850.040.040.08
Debt to assets
00.610.020.020.05
Net debt to EBITDA
0.32-0.5311.772.022.03
Current ratio
2.62.045.612.633.74
Interest coverage
-264.81-68.15-5.61-39.88-67.29
Income quality
1.040.87-4.021.781.15
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
1.592.420.920.851.32
Research and developement to revenue
3.242.482.337.920.93
Intangibles to total assets
0.050.040.010.010.04
Capex to operating cash flow
0.20.14-0.090.170.33
Capex to revenue
-1.14-0.7-0.97-1.24-1.38
Capex to depreciation
-3.89-1.71-4.44-8.16-3.93
Stock based compensation to revenue
-0.331.120.290.150.14
Graham number
1.291.767.9613.589.14
ROIC
-2.26-1.97-0.16-0.55-0.4
Return on tangible assets
-0.6-0.8-0.09-0.36-0.3
Graham Net
-0.15-0.712.962.091.14
Working capital
44.94M29.09M1.14B582.29M427.8M
Tangible asset value
25.87M-48.5M697.2M675.24M501.48M
Net current asset value
-20.51M-116.25M589.85M470.25M256.81M
Invested capital
0.01-1.850.040.040.08
Average receivables
012.27M9.75M10.16M28.97M
Average payables
07.18M11.48M69.94M95.25M
Average inventory
04.57M10.36M35.35M40.07M
Days sales outstanding
194.48370.6613.665.58213.5
Days payables outstanding
185.7369.54453.85187.35135.38
Days of inventory on hand
60.780.83374.2286.0647.59
Receivables turnover
1.880.9826.845.571.71
Payables turnover
1.975.250.81.952.7
Inventory turnover
6.014.520.984.247.67
ROE
-2.222.33-0.18-0.6-0.47
Capex per share
-0.08-0.07-0.26-0.69-0.49

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q3

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.060.060.030.030.07
Net income per share
-0.26-0.68-0.27-0.3-0.22
Operating cash flow per share
-0.2-0.26-0.47-0.29-0.27
Free cash flow per share
-0.35-0.37-0.53-0.35-0.33
Cash per share
2.952.652.932.432.09
Book value per share
3.42.823.372.92.69
Tangible book value per share
3.212.653.232.762.55
Share holders equity per share
3.42.823.372.92.69
Interest debt per share
0.230.230.20.190.21
Market cap
1.53B1.07B1.36B2.14B1.45B
Enterprise value
1.03B616.45M785.33M1.65B1.02B
P/E ratio
-8.06-2.08-5.93-7.95-7.43
Price to sales ratio
136.7791.55191.01282.787.76
POCF ratio
-42.69-21.8-13.67-33.42-23.88
PFCF ratio
-24.05-15.34-12.08-27.36-19.55
P/B Ratio
2.452.011.913.32.4
PTB ratio
2.452.011.913.32.4
EV to sales
92.2152.74110.16217.0662.15
Enterprise value over EBITDA
-25.59-4.88-15.42-27.35-26.16
EV to operating cash flow
-28.78-12.56-7.89-25.66-16.91
EV to free cash flow
-16.21-8.84-6.97-21-13.84
Earnings yield
-0.03-0.12-0.04-0.03-0.03
Free cash flow yield
-0.04-0.07-0.08-0.04-0.05
Debt to equity
0.070.080.060.060.07
Debt to assets
0.050.050.040.050.05
Net debt to EBITDA
12.363.5911.328.2710.78
Current ratio
3.613.747.613.863.56
Interest coverage
-96.64-192.87-63.46-40.27-13.23
Income quality
0.750.381.730.951.24
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
1.962.022.752.50.96
Research and developement to revenue
1.122.363.44.071.65
Intangibles to total assets
0.040.040.030.040.04
Capex to operating cash flow
0.780.420.130.220.22
Capex to revenue
-2.48-1.77-1.85-1.87-0.81
Capex to depreciation
-4.16-52.71-2.25-2.52-2.27
Stock based compensation to revenue
0.250.230.220.40.1
Graham number
4.446.574.544.433.63
ROIC
-0.07-0.2-0.08-0.1-0.08
Return on tangible assets
-0.05-0.16-0.06-0.08-0.06
Graham Net
1.451.141.781.411.14
Working capital
449.93M427.8M596.62M446.93M386.15M
Tangible asset value
591.21M501.48M682.8M617.35M571.8M
Net current asset value
336.76M256.81M426.64M352.78M296.53M
Invested capital
0.070.080.060.060.07
Average receivables
9.76M22.8M22.64M10.87M18.83M
Average payables
50.55M60.43M41.61M14.2M12.99M
Average inventory
10.55M15.93M24.33M23.44M22.75M
Days sales outstanding
49.53303.6573.76188.87118.76
Days payables outstanding
196.6376.7865.3146.7146.59
Days of inventory on hand
29.4126.99107.6377.2686.36
Receivables turnover
1.820.31.220.480.76
Payables turnover
0.461.171.381.931.93
Inventory turnover
3.063.330.841.161.04
ROE
-0.08-0.24-0.08-0.1-0.08
Capex per share
-0.15-0.11-0.06-0.06-0.06

5CV.DE Frequently Asked Questions

What is CureVac N.V. stock symbol ?

CureVac N.V. is a DE stock and trading under the symbol 5CV.DE

What is CureVac N.V. stock quote today ?

CureVac N.V. stock price is $2.85 today.

Is CureVac N.V. stock public?

Yes, CureVac N.V. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap